Jane Street
VYGR icon

Jane Street’s Voyager Therapeutics VYGR Stock Holding History

Jane Street’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Buy
+38,500
New +$146K ﹤0.01% 10425
2024
Q2 		– Sell
-21,300
Closed -$198K – 10261
2024
Q1 		$198K Buy
+21,300
New +$180K ﹤0.01% 8190
2022
Q3 		– Sell
-10,600
Closed -$63K – 10559
2022
Q2 		$63K Sell
10,600
-25,600
-71% -$173K ﹤0.01% 8850
2022
Q1 		$276K Buy
+36,200
New +$161K ﹤0.01% 8531

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jane Street's VYGR Position: Q2 2026 in Review

Jane Street reduced its Voyager Therapeutics (VYGR) stake by 70% in Q2 2026, selling an estimated $261K and leaving 29,170 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #10583.

Jane Street first reported a position in VYGR in Q3 2019 and has held it in 18 quarters since. The position peaked at $1.52M in Q2 2024. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Jane Street held 29,170 shares of Voyager Therapeutics worth $102K as of Q2 2026.
  • Jane Street sold 68,793 Voyager Therapeutics shares in Q2 2026, an estimated $261K.
  • Voyager Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10583 holding.
  • Jane Street first reported a position in Voyager Therapeutics in Q3 2019 and has held it in 18 quarters since.
  • Jane Street's Voyager Therapeutics position peaked at $1.52M in Q2 2024.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.